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Background
The use of lignocellulosic biomass rather than fossil fuel
is an environmental sustainable alternative for bioetha-
nol production. However, fermentation of lignocellulosic
hydrolysates by Saccharomyces cerevisiae is not viable
since this yeast cannot ferment xylose naturally. Cur-
rent, several studies are being developed to introduce a
pathway that allows pentose fermentation by S. cerevi-
siae [1]. The bacterium Propionibacterium acidipropio-
nici, employed in many industrial processes, is able to
efficiently ferment xylose using the enzyme xylose iso-
merase. Xylose isomerase, codified by the XI gene,
converts xylose to xylulose [2]. This study aims to
develop a yeast capable of fermenting xylose through
the expression of the P. acidipropioniciXI gene in S. cer-
evisiae. Furthermore, the effect of the over expression of
a gene that encodes a xylulokinase (XKS1) and the dele-
tion of the gene that codifies an aldose reductase (AR)
together with the expression of the XI gene were evalu-
ated. These enzymes are crucial for xylose fermentation
since the former converts xylulose to xylulose-5-P by
the pentose phosphate pathway (PPP) and the last
converts xylose into xylitol, which can alter the xylose
isomerase activity [3].
Methods
The sequence of the XI gene from P. acidipropionici was
obtained from its genome recently published [4]. An
industrial strain of S. cerevisiae derived from PE-2, A1
(haploid; URA3Δ), was used in this work. The URA3Δ
was used as an auxotrophic mark to select the transfor-
mants. The strategy chosen for heterologous expression
of the XI gene by S. cerevisiae was its introduction in a
high copy number plasmid. This plasmid contains the
URA3 gene and the XI gene was cloned with a
constitutive promoter and terminator. Three strategies
were used to evaluate the heterologous expression of
the XI gene: (1) expression of the XI gene alone; (2)
expression of the XI and overexpression of the XKS1
gene; (3) expression of the XI gene, overexpression of
XKS1 and deletion of the AR gene.
Results and conclusion
Tests of growth performed in a culture medium supple-
mented with xylose proved the great ability of P. acidi-
propionici to grow in this carbon source. Considering
that the codon usage of S. cerevisiae is substantially dif-
ferent from the P. acidipropionici and given that this
bacterium has a high GC content, an optimization of
the codons from the XI gene was performed. By this
way, the codon adaptation index (CAI), initially 0.49,
raised to 0.93 after the optimization. The optimized
gene was synthetized and the yeast was transformed
with the XI cassette. Preliminary fermentation tests in
medium containing xylose as carbon source showed that
these yeasts were still not able to ferment xylose. Analy-
sis of RNA samples from all lineages confirmed that the
XI is expressed. Since the majority of the XI sequences
are protected by patents and the gene from this bacter-
ium is not protected, many efforts are being done to
understand the reason why this bacterial gene is not
functional in S. cerevisiae.
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